首页 > 市场调查报告书 > 医疗设备

体外诊断

胆固醇检测市场规模、份额和成长分析（按产品、检测方法、年龄层、应用、分销管道、服务提供者和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1902718

胆固醇检测市场规模、份额和成长分析（按产品、检测方法、年龄层、应用、分销管道、服务提供者和地区划分）—产业预测（2026-2033 年）

Cholesterol Test Market Size, Share, and Growth Analysis, By Product (Testing Kits, Testing Strips), By Test, By Age Group, By Application, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 218 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球胆固醇检测市场规模将达到 79.9 亿美元，到 2025 年将成长至 86.6 亿美元，到 2033 年将成长至 165.1 亿美元，预测期（2026-2033 年）的复合年增长率为 8.4%。

全球胆固醇检测市场正经历显着成长，其主要驱动因素是与久坐生活方式和不健康饮食习惯相关的心血管疾病盛行率不断上升。人们对预防性医疗保健的日益重视以及对定期筛检重要性的认识不断提高，推动了对胆固醇管理解决方案的需求。创新照护现场设备和家用检测套组等技术进步，进一步提升了胆固醇测量的可近性和准确性。此外，人口老化加剧，老年人更容易受到高胆固醇的影响，这也显着增加了对检测服务的需求。儘管仍存在一些挑战，例如诊断检查室短缺和法规环境严格，但投资医疗基础设施和持续技术创新仍蕴藏着机会。总而言之，胆固醇检测产业具有巨大的扩张和创新潜力，凸显了其在心血管健康管理中的关键作用。

全球胆固醇检测市场驱动因素

心血管疾病（包括心臟病和中风）的流行仍然是全球范围内导致发病率和死亡率的主要原因。这种日益严重的担忧凸显了胆固醇检测在心血管风险评估中的重要性，进而推动了对胆固醇检测产品和服务的需求。随着个人和医疗保健提供者越来越认识到胆固醇水平与心臟健康之间的关联，由于在预防和管理心血管疾病方面对有效评估工具的持续需求，胆固醇检测市场也相应扩大。这一趋势证实了胆固醇检测在现代医学中的关键作用。

限制全球胆固醇检测市场的因素

胆固醇检测费用高昂，对资源匮乏和用户族群而言尤其如此，构成重大挑战。高昂的检测费用阻碍了人们定期进行胆固醇检测，尤其是在低收入族群。这种经济障碍不仅限制了人们获得基本医疗服务的机会，也阻碍了有效的胆固醇监测和管理，可能导致更差的健康结果。解决这些与费用相关的问题对于提高检测率和促进弱势群体心血管疾病的预防至关重要。

全球胆固醇检测市场趋势

全球胆固醇检测市场正经历着向先进检测技术的显着转变，其特点是不断创新，以提高检测的准确性和便利性。关键发展包括就地检验设备、非侵入性调查方法以及旨在简化胆固醇测量流程的高灵敏度检测技术。此外，这些检测解决方案与数位健康平台、电子健康记录(EHR) 和远端医疗系统的整合日益普及，促进了远端监测和全面的资料管理。这种整合不仅简化了病患参与流程，也增强了不同医疗机构的胆固醇管理流程，体现了心血管健康监测领域的变革性方法。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Abbott Laboratories（USA）
F. Hoffmann-La Roche Ltd.（Switzerland）
Siemens Healthineers AG（Germany）
Thermo Fisher Scientific Inc.（USA）
Danaher Corporation（USA）
PerkinElmer, Inc.（USA）
Bio-Rad Laboratories, Inc.（USA）
Randox Laboratories Ltd.（UK）
Eurofins Scientific（Luxembourg）
Novartis AG（Switzerland）
Merck KGaA（Germany）
Beckman Coulter Inc.（USA）
Boston Heart Diagnostics Corporation（USA）
Quest Diagnostics Incorporated（USA）
Laboratory Corporation of America Holdings（Labcorp）（USA）
QuidelOrtho Corporation（USA）
Helena Laboratories Corporation（USA）
Sekisui Chemical Co., Ltd.（Japan）
Sinocare Inc.（China）

结论与建议

简介目录

Product Code: SQMIG35A2894

Global Cholesterol Test Market size was valued at USD 7.99 Billion in 2024 and is poised to grow from USD 8.66 Billion in 2025 to USD 16.51 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global cholesterol testing market is witnessing substantial growth, propelled by rising cardiovascular disease prevalence linked to sedentary lifestyles and unhealthy dietary choices. Increasing awareness of preventive healthcare and the importance of regular screenings enhances demand for cholesterol management solutions. Technological advancements, like innovative point-of-care devices and home testing kits, further facilitate accessibility and accuracy of cholesterol measurements. Additionally, the aging population, more susceptible to high cholesterol levels, significantly drives the need for testing services. While challenges such as a shortage of diagnostic labs and stringent regulatory environments persist, opportunities lie in investment in healthcare infrastructure and ongoing technological innovations. Overall, the cholesterol testing sector presents vast prospects for expansion and innovation, underscoring its critical role in managing cardiovascular health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholesterol Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholesterol Test Market Segments Analysis

Global Cholesterol Test Market is segmented by Product, Test, Age Group, Application, Distribution Channel, Service Provider and region. Based on Product, the market is segmented into Testing Kits, Testing Strips and Others. Based on Test, the market is segmented into Total Cholesterol Tests, High Density Lipoprotein (HDL) Cholesterol Tests, Low Density Lipoprotein (LDL) Cholesterol Tests, Triglyceride Tests and Others. Based on Age Group, the market is segmented into Geriatric, Adult and Pediatric. Based on Application, the market is segmented into Cardiovascular Diseases, Diabetes, Obesity, Hyperlipidemia and Others. Based on Distribution Channel, the market is segmented into Over the Counter and Prescription Based. Based on Service Provider, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Ambulatory Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cholesterol Test Market

The prevalence of cardiovascular diseases, such as heart disease and stroke, continues to be a significant source of illness and death around the globe. This growing concern emphasizes the importance of cholesterol testing in evaluating cardiovascular risk, which in turn fuels the demand for cholesterol testing products and services. As individuals and healthcare providers increasingly recognize the correlation between cholesterol levels and heart health, the market for cholesterol tests expands accordingly, driven by the ongoing necessity for effective assessment tools in the prevention and management of cardiovascular conditions. This trend underscores the critical role of cholesterol testing in modern healthcare.

Restraints in the Global Cholesterol Test Market

The expense associated with cholesterol testing presents a considerable challenge, particularly in areas with constrained healthcare resources or among populations without insurance coverage. Elevated testing costs can discourage individuals from participating in regular cholesterol screenings, which is especially true for those belonging to lower socioeconomic backgrounds. This financial barrier not only limits access to essential health services but also hinders efforts to monitor and manage cholesterol levels effectively, potentially leading to detrimental health outcomes. Addressing these cost-related issues is crucial to improving screening rates and fostering better overall cardiovascular health within vulnerable communities.

Market Trends of the Global Cholesterol Test Market

The Global Cholesterol Test market is experiencing a notable shift towards advanced testing technologies, characterized by innovations that enhance accuracy and accessibility. Key developments include point-of-care testing devices, non-invasive testing methodologies, and high-sensitivity assays, all designed to improve efficiency in cholesterol measurement. Additionally, the integration of these testing solutions with digital health platforms, electronic health records (EHRs), and telemedicine systems is increasingly prevalent, facilitating remote monitoring and comprehensive data management. This integration not only streamlines patient engagement but also enhances cholesterol management processes within diverse healthcare environments, reflecting a transformative approach to cardiovascular health monitoring.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Cholesterol Test Market Size by Product & CAGR (2026-2033)

Market Overview
Testing Kits
Testing Strips
Others

Global Cholesterol Test Market Size by Test & CAGR (2026-2033)

Market Overview
Total Cholesterol Tests
High Density Lipoprotein (HDL) Cholesterol Tests
Low Density Lipoprotein (LDL) Cholesterol Tests
Triglyceride Tests
Others

Global Cholesterol Test Market Size by Age Group & CAGR (2026-2033)

Market Overview
Geriatric
Adult
Pediatric

Global Cholesterol Test Market Size by Application & CAGR (2026-2033)

Market Overview
Cardiovascular Diseases
Diabetes
Obesity
Hyperlipidemia
Others

Global Cholesterol Test Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Over the Counter
Prescription Based

Global Cholesterol Test Market Size by Service Provider & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Diagnostic Laboratories
Ambulatory Care Centers
Others

Global Cholesterol Test Market Size & CAGR (2026-2033)

North America (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
- US
- Canada
Europe (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Heart Diagnostics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (Labcorp) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helena Laboratories Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sekisui Chemical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sinocare Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments